Bridgeway Capital Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.3K Hold
61,000
﹤0.01% 1165
2026
Q1
$78.7K Sell
61,000
-4,800
-7% -$7.93K ﹤0.01% 1153
2025
Q4
$145K Hold
65,800
﹤0.01% 1070
2025
Q3
$107K Hold
65,800
﹤0.01% 1101
2025
Q2
$170K Hold
65,800
﹤0.01% 993
2025
Q1
$443K Buy
65,800
+2,900
+5% +$20.5K 0.01% 764
2024
Q4
$427K Sell
62,900
-5,400
-8% -$35.6K 0.01% 850
2024
Q3
$566K Buy
+68,300
New +$494K 0.01% 833

Other funds holding LUNG

Bridgeway Capital Management's LUNG Position: Q2 2026 in Review

Bridgeway Capital Management held its Pulmonx (LUNG) position steady in Q2 2026 at 61,000 shares worth $79.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Bridgeway Capital Management first reported a position in LUNG in Q3 2024 and has held it in 8 quarters since. The position peaked at $566K in Q3 2024. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Bridgeway Capital Management held 61,000 shares of Pulmonx worth $79.3K as of Q2 2026.
  • Bridgeway Capital Management left its Pulmonx share count unchanged in Q2 2026.
  • Pulmonx made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1165 holding.
  • Bridgeway Capital Management first reported a position in Pulmonx in Q3 2024 and has held it in 8 quarters since.
  • Bridgeway Capital Management's Pulmonx position peaked at $566K in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.